RareMed has done it again! After being the ONLY specialty pharmacy entity to earn a top-three spot in MMIT’s patient satisfaction survey EVERY quarter for the past two years (and beyond), RareMed has earned MMIT’s inaugural Patient Choice Award for Specialty Pharmacy Hubs 2025. The finalists and winners are calculated based on the highest average net promoter scores (NPS) from MMIT’s Specialty Pharmacy Patient Satisfaction Survey. The award was announced at Asembia’s ASX25 Specialty Pharmacy Summit in Las Vegas and was displayed at RareMed’s “Accelerating Patient Access” event at the McLaren Experience inside the Wynn Hotel at the conference.
“Winning MMIT’s inaugural Patient Choice Award in the hub category is vindication of all of the efforts we put forth every day to prioritize patient experience,” said RareMed President Doug Gebhard. “We differentiate ourselves by delivering the absolute best patient care in the industry. When biopharma wants to elevate the quality of their patient experiences, they call RareMed. And I’m so proud to be part of a team that delivers this level of quality service to patients every day.”
Many factors and metrics go into MMIT’s award selection process, including prescription and refill time, time to speak with a representative, satisfaction with pharmacy, on-time delivery of medications, timeliness, and commentary regarding customer service. As patient care advocates, setting and maintaining high standards of care is fundamental to how RareMed differentiates itself, and we continuously invest to solidify our tradition of providing best-in-class patient care.
RareMed is proud to accept the MMIT Patient Choice Award in the newly established pharmacy hubs category. The company has regularly achieved the #1 ranking in patient satisfaction and continuously works to make sure that high level of patient care excellence is maintained! Historically, RareMed has scored as high as a record-setting 98pts in MMIT’s Net Promoter Score calculation, a direct result of RareMed’s commitment to our mission to accelerate care to patients suffering from complex conditions. By prioritizing patient satisfaction and operational excellence, RareMed stands as the industry leader in specialty pharmacy hub services, allowing us to positively impact the lives of patients with complex conditions every day.
We are honored to have earned this new award, and look forward to contending for it in the future.
About RareMed
RareMed Solutions is the nation’s only concierge patient services provider, focused on rare and complex conditions. RareMed partners with biopharma to transform the lives of patients afflicted with rare and devastating conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all 50 states, as well as custom-developed associated support technologies, from its headquarters in Pittsburgh, Pennsylvania and bases in North Carolina, Florida, and Arizona.
The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction. RareMed’s undivided complex and rare disease focus, high caliber associates, fully dedicated teams, and sophisticated proprietary technology enable it to address the unique needs of complex and rare disease patients. RareMed was recently voted the #1 large employer to work for in the City of Pittsburgh according to Pittsburgh Business Times and is a finalist in USA Today’s nationwide Top Workplaces program for 2024. Visit our website at www.RareMed.com.
About Net Promoter Score
The primary component of the MMIT Patient Satisfaction Survey is the Net Promoter Score (NPS). NPS is calculated by first asking patients how likely they would be to recommend a pharmacy to a friend or family member on a scale of 0-10. The percentage of patients that rate the pharmacy a 0-6, known as detractors, is subtracted from the percentage of patients that rate the pharmacy a 9 or 10, known as promoters, to create a score that ranges from –100 to 100. NPS is used by consumer facing companies to gauge consumer and brand loyalty.
About MMIT
For nearly two decades MMIT has been solely focused on solving the “what and why” of drug coverage and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn’t face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions.
Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry.